Answer
The safety and efficacy of pegvisomant (Somavert) in children aged 0 to 17 years have not been established, and no data are available.
Sources for this answer
- SOMAVERT 10mg powder and solvent for solution for injectionPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 26Document updated
Sources checked